Biosimulytics

Biosimulytics is a spin-off company from the School of Chemical and Bioprocess Engineering at University College Dublin (UCD), Ireland. Biosimulytics has developed groundbreaking technology that combines quantum physics, computational chemistry, machine learning, and high-performance computing to accurately and rapidly predict the most favorable force field energy configurations and crystal structure packing of new drug compounds. This supports the pharmaceutical industry in addressing polymorphism issues and accelerates the journey from molecule to medicine (M2M) with greater success probability.